Untitled Document
www.expresshealthcare.in INSIGHT INTO THE BUSINESS OF HEALTHCARE
February 2010  
Untitled Document
Sections

Market
Healthcare World
IT@Healthcare
Knowledge
Strategy
Criticare
Healthcare Life

Specials

In Imaging 2009
Criticare Frontiers 2009

Services
Subscribe/Renew
Archives/Search
Contact Us
Network Sites
Express Computer
Exp. Channel Business
Express Hospitality
Express TravelWorld
Express Pharma
Group Sites
ExpressIndia
Indian Express
Financial Express

Home - Market - Article

HospiNews

Moolchand Performs Surgery for Bilateral Wilm's Tumor

A rare surgery on four-year-old boy from Iraq suffering from Bilateral Wilms' Tumor (renal nephroblastoma) was successfully performed at New Delhi’s Moolchand Medcity, recently. A team of super-specialists physicians (including general surgeon, urologist, uro-surgeon and pediatrician) from Moolchand took the challenge and performed the rare surgery by removing the tumor from both the kidneys (tumor size in left kidney=2.5x2.5x2.5 and in right kidney=8x7x8) with minimal blood loss.

"The patient was in advanced stage when he came to us for the treatment. After chemotherapy in Iraq, his stage regressed for a while but relapsed again so he was referred for surgical excision. Considering the rarity of the disease, it was a challenging job to perform this surgery on such a small child. We removed both sides tumors at one sitting. It took almost three and a half hours to perform the rare surgery and only 150cc of blood was required to be transfused to the patient," said Dr Anil Malik, General Surgeon, Moolchand Medcity. At present, the patient is normal and moving towards fast recovery.

Wilm's tumor is the fifth most common paediatric malignancy and the most common type of renal tumor in children. Most nephroblastomas are unilateral; being bilateral is less than five per cent of cases. Bilateral Wilm's tumor is a rare condition of kidney tumor that typically occurs in children and it is very rare in adults. The majority of the cases (75 per cent) occur in otherwise normal children; and a minority (25 per cent) is associated with other developmental abnormalities. It is highly responsive to treatment, with about 90 per cent of patients surviving at least five years. It is mostly inoperable. It is a congenital defect and is prevalent in children up to seven years of age. Most of the children die because of delay in diagnosis and lack of medical facilities.

EH News Bureau

 


Untitled Document

FEEDBACK: We would love to hear from you -- what you like about our content, what you dont, and even how you think we can improve. Please send your feedback to: healthcare@expressindia.com


© Copyright 2001: The Indian Express Limited. All rights reserved throughout the world. This entire site is compiled in Mumbai by the Business Publications Division (BPD) of The Indian Express Limited. Site managed by BPD.